John David Finley - 03 Jan 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
Chief Executive Officer
Signature
/s/ JD Finley
Issuer symbol
PALI
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
06 Jan 2023, 18:42:07 UTC
Previous filing
02 Sep 2022
Next filing
08 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Award $0 +5,236 $0.000000 5,236 03 Jan 2023 Common Stock 5,236 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a one-time retention grant to Reporting Person valued at $20,000 on the date of grant based on the closing price of the Issuer's common stock on the date of grant. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 4/3/23, 7/3/23, 10/3/23, and 1/3/24.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. The restricted stock units were issued from the Issuer's 2021 Equity Incentive Plan.
F3 N/A